Akari Therapeutics Inc (NASDAQ:AKTX), Allego Inc (NYSE:ALLG) – Why Tuesday morning stocks fell 31%; Here are 66 greatest movers of yesterday

Winners

  • NeuroBo Pharmaceuticals, Inc. NRBO jumped 101.3% to settle at $0.5558 on Monday after the company announced a 1-for-30 reverse stock split.
  • InMed Pharmaceuticals Inc. IN M gained 70.4% to close at $18.78 after the company announced a $6 million private placement Friday at $8.68 per share.
  • Ventyx Biosciences, Inc. VTYX shares jumped 65% to close at $38.11 on Monday after Oppenheimer maintained an outperform rating on the stock and raised its price target from $40 to $65.
  • PolyPid Ltd. PYPD gained 58.3% to close at $1.71. The company announced earlier that it will present phase 2 data from D-PLEX₁₀₀ at the European Society of Coloproctology scientific conference next week.
  • Arqit Quantum Inc. ARQQ shares gained 38.1% to close at $7.72. The company will present at the 24th Annual HC Wainwright Global Investment Conference later today.
  • PaxMedica, Inc. PXMD rose 36.6% to settle at $4.33 after TardiMed Sciences’ Michael Derby on Friday disclosed a 63.4% working stake in the company.
  • Allego S.A. ALLG jumped 33.5% to close at $5.90.
  • IDEAYA Biosciences, Inc. IDYA jumped 30.7% to close at $12.09. IDEAYA Biosciences has unveiled interim Phase 2 clinical results for the synthetic lethal combination of darovasertib and crizotinib in metastatic uveal melanoma.
  • Clovis Oncology, Inc. CLVS climbed 30.4% to close at $1.50 after the company said Rubraca (Rucaparib) as first-line maintenance treatment improves progression-free survival in women with breast cancer advanced ovary in all disease risk subgroups.
  • Annovis Bio, Inc. ANVS gained 29.5% to settle at $19.82 on above average volume.
  • Kaspien Management Inc. KSPN jumped 27.7% to close at $2.86.
  • IHS Holding Limited IHS jumped 24.9% to close at $7.83. IHS Holding last month said second-quarter EPS results were down year-over-year.
  • Gogoro inc. GGR gained 21.3% to close at $5.25. Gogoro recently launched its battery swap system and smart scooters in the Tel Aviv metropolitan area.
  • ImmunityBio, Inc. IBRX jumped 20.9% to close at $5.61.
  • POINT Biopharma Global Inc. NTP rose 19.8% to close at $10.27 after the company released a poster at ESMO Congress 2022 highlighting updated safety and efficacy data from its Phase 3 SPLASH trial of PNT2002 in metastatic castration-resistant prostate cancer.
  • Rackspace Technology, Inc. RXT gained 18.8% to settle at $6.32.
  • Magic Empire Global Limited DELG jumped 17.9% to close at $6.00.
  • Regulus Therapeutics Inc. RGLS rose 16.9% to close at $1.94 after the company announced safety and PK data from its SAD Phase 1 clinical trial of RGLS8429. The study demonstrated that RGLS8429 has a favorable safety and pharmacokinetic profile.
  • TuanChe Limited CT gained 16.8% to close at $3.20.
  • Asana, Inc. ASAN climbed 16.4% to close at $28.71. Asana President, CEO and Director Dustin Moskovitz purchased a total of 19,273,127 shares at an average price of $18.16.
  • Carvana Co. CVNA gained 15.5% to close at $42.28. Piper Sandler moved Carvana from neutral to overweight and lowered the price target from $98 to $73.
  • Ra Medical Systems, Inc. RMED jumped 15.1% to close at $0.1675 after the company announced a merger deal with Catheter Precision. Catheter Precision will become a wholly owned subsidiary of Ra Medical.
  • Finance Of America Companies Inc. AOF gained 15.1% to settle at $1.60.
  • American Rebel Holdings, Inc. AREB gained 14.7% to close at $0.6650.
  • American Rebel CEO Andy Ross released a company update in a letter to shareholders.
  • Rhythm Pharmaceuticals, Inc. RYMC jumped 13.6% to close at $26.46.
  • NIO inc. NIO jumped 13.5% to close at $21.75 on positive coverage from analysts at Deutsche Bank and BofA.
  • Vinco Ventures, Inc. BIG rose 13% to close at $1.13.
  • SpringWorks Therapeutics, Inc. SWTX gained 12.8% to close at $31.98 after the company announced that data from the DeFi Phase 3 trial of nirogacestat in adult patients with desmoid tumors showed that treatment with nirogacestat resulted in rapid, sustained and statistically significant improvements in key secondary efficacy endpoints.
  • Cardlytics, Inc. CDLX rose 12.2% to close at $14.31.
  • Audia Inc. AUUD gained 12% to settle at $1.40.
  • Sigma Lithium Corporation SGML gained 11.4% to close at $27.81.
  • Ribbon Communications Inc. RBBN jumped 10.5% to close at $3.57.
  • Quhuo Limited QH Shares gained 10.2% to close at $3.03 after the company said Friday it had decided not to proceed with its proposed stock offering and sale.
  • LucidGroup, Inc. LCID jumped 9.7% to close at $16.55 after RF Lafferty hedged the stock with a buy rating and price target of $19.
  • NetScout Systems, Inc. NTCT rose 9.4% to close at $33.60. The company last month released upbeat quarterly results.
  • Cafe Reborn, Inc. REBN rose 8.4% to close at $2.57. Dennis R Egidi recently announced a 9.5% stake in Reborn Coffee.
  • Wayfair Inc. O gained 7.7% to settle at $55.95 amid overall market strength as investors await inflation data this week.
  • Genenta Science SpA GNTA rose 7.5% to close at $5.15.
  • Hyperfine, Inc. HYPR gained 7.4% to close at $1.31 after falling 6% on Friday. Hyperfine last month reported worse-than-expected second-quarter EPS and sales results and issued fiscal 22 sales guidance that fell short of estimates.
  • Eve Holding, Inc. EVEX gained 5.7% to close at $8.15. United recently announced a $15 million investment in Eve Air Mobility and a conditional purchase agreement for 200 four-seat electric aircraft plus 200 options.
  • Bristol-Myers Squibb Company BMY gained 3.1% to settle at $72.36. The FDA has approved Bristol Myers Squibb Co.’s Sotyktu (deucravacitinib), an allosteric tyrosine kinase 2 (TYK2) inhibitor, for moderate to severe plaque psoriasis that is a candidate for systemic therapy or phototherapy. Atlantic Equities kept Bristol-Myers Squibb overweight and raised the price target from $83 to $87.

losers

  • Tuesday morning society TUEM fell 31.2% to close at $0.1937. The company announced Friday that it has reached an agreement to secure $32 million in convertible debt financing.
  • WeTrade Group, Inc. WETG fell 30.2% to close at $1.11 on above average volume.
  • Akari Therapeutics, Plc AKTX shares fell 27.9% to close at $0.75 on Monday after the company announced a registered direct offering of $12.75 million.
  • Yoshiharu Global Co. YOSH shares fell 26.9% to close at $3.05. On Friday, the company priced its IPO at $4 per share.
  • Ayala Pharmaceuticals, Inc. AYLA fell 25.9% to close at $1.40. Ayala Pharmaceuticals presented interim data from RINGSIDE’s pivotal Phase 2/3 trial of AL102 showing confirmed partial response in desmoid tumors at the ESMO Congress.
  • Intellinetics, Inc. INLX fell 22.9% to settle at $4.58 as the stock shed last week’s gains. The company recently announced an uplisting on the NYSE.
  • Goosehead Insurance, Inc. GSHD fell 21.9% to close at $42.28. Goosehead Insurance has appointed Mark Jones, Jr as its new Chief Financial Officer.
  • ShiftPixy, Inc. FAIRY fell 20.8% to close at $27.28 amid profit taking after the stock surged last week following the company’s announcement of plans to spin off ShiftPixy Labs and distribute its securities digital to shareholders.
  • Entrada Therapeutics, Inc. TRDA fell 20.2% to close at $11.91. Entrada Therapeutics last month posted a loss of $0.74 per share in the second quarter.
  • Leap Therapeutics, Inc. LPTX fell 20.1% to close at $1.35.
  • DICE Therapeutics, Inc. OF fell 16.5% to close at $18.91. Stifel last week initiated a hedge on the stock with a buy rating and a price target of $37.
  • Immatics S.A. IMTX fell 15.2% to close at $10.90.
  • Great Panther Mining Limited LPG fell 14.1% to close at $0.2028.
  • United-Guardian, Inc. U G fell 12.9% to settle at $12.82. United-Guardian last month reported second-quarter EPS of $0.14.
  • AnPac ​​Bio-Medical Science Co., Ltd. ANPC fell 12.8% to close at $0.1767.
  • T Inc stamp IDAI fell 12.4% to close at $1.55.
  • Nuwellis, Inc. NUWE fell 11.2% to close at $0.7547.
  • Sarcos technology and robotics company CSTR fell 11% to settle at $3.47.
  • Vertex Energy, Inc. VTNR fell 9.9% to close at $7.83. Vertex Energy has announced the extension of Mobile Refinery’s mechanical completion target to the first quarter of 2023.
  • Lesaka Technologies, Inc. LSAK fell 9.3% to settle at $4.69.
  • MOGU Inc. MOGU fell 9.2% to close at $2.36. Mogu’s board on Friday authorized a new share buyback program of up to $10 million of its stock.
  • Apdemanden, Inc. APGN fell 8.7% to close at $6.95 as the company announced the presentation of new data from a Phase 2 trial evaluating sotigalimab (sotiga) in combination with neoadjuvant chemoradiotherapy for resectable breast cancers. esophagus and gastroesophageal junction (GEJ).
  • CleanTech Acquisition Corp. CLAQ fell 8.2% to close at $5.60. CleanTech Acquisition and Nauticus Robotics have entered into a business combination to trade under “KITT” effective September 13.
  • Intrepid Potash, Inc. IPI fell 8.2% to settle at $43.09.
  • Codere Online Luxembourg, SA CDRO fell 6.3% to close at $3.00. Codere Online recently released second quarter sales results.

Comments are closed.